Mr. Speaker, I am well aware of the needs of victims of multiple sclerosis.
Unfortunately, the manufacturers of Betaseron chose not to apply to have the drug approved here in Canada at the same time as they did in the U.S. When they did apply we fast tracked the approval of this drug. The price of this drug is quite high. It is under review at this time by the Patented Medicine Prices Review Board.